Insiders Buying Freshpet And 2 Other Stocks
Portfolio Pulse from Lisa Levin
Insiders have recently purchased shares in Funko, Inc. (FNKO), Freshpet, Inc. (FRPT), and Aclaris Therapeutics, Inc. (ACRS). This could indicate confidence in the companies' prospects or that the insiders view the stocks as bargains. However, insider purchases should not be the sole indicator for making investment or trading decisions.
August 29, 2023 | 11:21 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Aclaris Therapeutics' Chief Business Officer James Loerop bought 14,705 shares at an average price of $6.80. The company recently reported a net loss of $29.6 million for Q2.
While the insider purchase could indicate confidence in the company, the recent net loss could negatively impact the stock price in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
NEUTRAL IMPACT
Funko's 10% owner Chan Kenneth Hsiang-Tze acquired 35,699 shares at an average price of $6.11. The company recently reported a Q2 earnings miss and issued weak guidance.
While the insider purchase could indicate confidence in the company, the recent earnings miss and weak guidance could negatively impact the stock price in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Freshpet's Director Walter George acquired 1,000 shares at an average price of $73.53. The company recently entered into a cooperation agreement with JANA Partners, one of its largest shareholders.
The insider purchase, combined with the recent cooperation agreement with a major shareholder, could positively impact the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100